Sex differences in lipid profile across the life span in patients with type 2 diabetes: A primary care-based study

Martina Ambrož*, Sieta T. de Vries, Priya Vart, Robin P.F. Dullaart, Jeanine Roeters van Lennep, Petra Denig, Klaas Hoogenberg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
1 Downloads (Pure)

Abstract

We assessed sex differences across the life span in the lipid profile of type 2 diabetes (T2D) patients treated and not treated with statins. We used the Groningen Initiative to ANalyze Type 2 diabetes Treatment database, which includes T2D patients from the north of the Netherlands. Patients with a full lipid profile determined between 2010 and 2012 were included. We excluded patients treated with other lipid-lowering drugs than statins. Sex differences in low-and high-density lipoprotein cholesterol (LDL-c and HDL-c) and triglyceride (TG) levels across 11 age groups strati-fied by statin treatment were assessed using linear regression. We included 26,849 patients (51% women, 55% treated with statins). Without statins, women had significantly lower LDL-c levels than men before the age of 45 years, similar levels between 45 and 49 years, and higher levels there-after. With statins, similar LDL-c levels were shown up to the age of 55, and higher levels in women thereafter. Women had significantly higher HDL-c levels than men, regardless of age or statin treat-ment. Men had significantly higher TG levels up to the age of 55 and 60, depending on whether they did not take or took statins, respectively, and similar levels thereafter. When managing cardiovascular risk in patients with T2D, attention is needed for the menopausal status of women and for TG levels in younger men.

Original languageEnglish
Article number1775
JournalJournal of Clinical Medicine
Volume10
Issue number8
DOIs
Publication statusPublished - 19 Apr 2021

Fingerprint

Dive into the research topics of 'Sex differences in lipid profile across the life span in patients with type 2 diabetes: A primary care-based study'. Together they form a unique fingerprint.

Cite this